Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xencor Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
XNCR
Nasdaq
2834
https://xencor.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xencor Inc
Xencor Appoints Bart Cornelissen as Chief Financial Officer
- Apr 9th, 2024 12:01 pm
Insider Sell: SR. VICE PRESIDENT & CFO John Kuch Sells 4,474 Shares of Xencor Inc (XNCR)
- Mar 8th, 2024 10:01 pm
Insider Sell: President & CEO Bassil Dahiyat Sells 12,528 Shares of Xencor Inc (XNCR)
- Mar 7th, 2024 10:00 pm
Xencor Full Year 2023 Earnings: Misses Expectations
- Feb 29th, 2024 10:33 am
Xencor to Present at Upcoming Investor Conferences
- Feb 28th, 2024 9:01 pm
Q4 2023 Xencor Inc Earnings Call
- Feb 28th, 2024 2:35 pm
Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 1:38 pm
Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates
- Feb 27th, 2024 10:20 pm
Xencor Inc (XNCR) Reports Mixed Financial Results for Q4 and Full Year 2023
- Feb 27th, 2024 9:39 pm
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 27th, 2024 9:01 pm
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
- Feb 20th, 2024 9:31 pm
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
- Feb 19th, 2024 8:37 am
Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release
- Feb 15th, 2024 3:00 pm
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 9:01 pm
Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock?
- Jan 3rd, 2024 2:55 pm
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
- Jan 2nd, 2024 1:01 pm
Insider Sell: Xencor Inc President & CEO Bassil Dahiyat Sells 45,000 Shares
- Dec 30th, 2023 10:02 pm
Xencor (NASDAQ:XNCR) shareholders are up 7.7% this past week, but still in the red over the last three years
- Dec 10th, 2023 12:04 pm
Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 9:01 pm
Things Look Grim For Xencor, Inc. (NASDAQ:XNCR) After Today's Downgrade
- Nov 13th, 2023 10:02 am
Scroll